โ† Every issue

MedTech Leading Voice ยท Issue 188 ยท 1 Nov 2026

Industry Groups Back a Single Regulatory Pathway for AI-Enabled Medical Devices

Six European organizations, including MedTech Europe and COCIR, are backing the European Commission's proposal for a single regulatory pathway for AI enabled medical devices and diagnostics. The issue notes that this support was highlighted by Achraf Tahar this week.

By Sean Smith Read on LinkedIn โ†—
Issue 188 cover

Industry Groups Back a Single Regulatory Pathway for AI-Enabled Medical Devices

MedTech Leading Voice | Issue 188

๐Ÿ“ From the Editor

Six European organizations, including MedTech Europe and COCIR, are backing the European Commission's proposal for a single regulatory pathway for AI-enabled medical devices and diagnostics, as Achraf Tahar highlighted this week. Easy Medical Device, Christian Kaestner and Stefano Bolletta covered the EU AI Act, the upcoming IEC 62304 revision and a new ISO white paper on healthcare AI risks.

I had a great time in Europe, and I'm glad to be home with my dog and family.

Last week brought two strong sessions: commercial training and human factors validation with ClariMed and Cumby Consulting, and AI pre-submission review under the MDR with the co-founders of phablo.ai. We're heading into the final stretch of the year.

โ€” Sean Smith

๐Ÿง  Featured Post

Industry Groups Back a Single Regulatory Pathway for AI-Enabled Medical Devices

A joint position paper from COCIR, DIGITALEUROPE, EFPIA, ESTRO, EUCOPE and MedTech Europe supports the European Commission's proposal for a single regulatory pathway for AI-enabled medical devices and diagnostics. The proposal would avoid parallel, potentially overlapping regulatory processes under the MDR/IVDR and the EU AI Act.

Achraf Tahar called the paper an important signal for the future of AI-enabled medical technologies in Europe. For MedTech teams building AI into devices or diagnostics, it is a proposal to follow closely. Easy Medical Device's latest EMD Magazine also looked at the EU AI Act's impact on medical device regulation this week.

View the post >>

๐Ÿ“Œ This Week's Top Posts (In no special order)

๐ŸŽฏ Featured Event

Methodological Quality and Scientific Validity Under the MDR

Friday, November 6, 2026, 11:00 AM ET โ€” When the study is complete, will the data stand up to scrutiny? This Friday In-Focus features Maria E. Donawa, M.D., Founder and President of Donawa Lifescience. Maria brings more than 40 years of US and EU regulatory experience, including time at FDA, and has evaluated clinical evaluation plans and reports for more than 20 years. She is a member of ISO TC 194 WG 4, the working group behind ISO 14155.

Register Now >>

๐Ÿ—“๏ธ Upcoming Events & Webinars


๐ŸŽŸ๏ธ Upcoming Conferences

  • November 3โ€“5 | San Diego, CA โ€” MedTech Strategist Innovation Summit San Diego 2026 at The US Grant Hotel. A medical device partnering and investment conference. Attendee registration covers all sessions, meals, networking, and the JuJama partnering app. Register Now >>
  • November 10โ€“11 | Philadelphia, PA โ€” PhMTI 2026 Fall Seminar: Human + Machine, The Enduring Value of Information Professionals in the Age of AI, at the Sofitel Philadelphia at Rittenhouse Square. Member rate $200. Register Now >>

๐Ÿ’ฅ Weekly 510(k) Roundup

October 26, 2026 | From Marcus Engineering, LLC

56 clearances this week, including 20 first-time clearances (๐Ÿš€). Featured clearances:

  • ๐Ÿš€ Rhythm.ai โ€” STAR Apollo Mapping System: uses AI to analyze the heart's electrical activity and map areas that may be causing atrial fibrillation (AFib), helping doctors pinpoint where treatment is needed.
  • RIVANNA โ€” Accuro XV: a handheld probe uses sound waves to create 3D ultrasound images of bone and surrounding tissue without X-rays. Its newly FDA-cleared BoneEnhance technology uses AI to highlight different structures in color.
  • ๐Ÿš€ Avicenna.AI โ€” CINA-Aneurysm: uses AI to examine CT images and flag suspicious areas for radiologists to review, helping catch brain aneurysms before they become an emergency.

Explore the update >>

๐Ÿ“‹ Regulatory Roundup

28 September 2026 | By Martin King

This week's regulatory signals are moving from policy to implementation. Across medicines, medical devices and IVDs, regulators are sharpening expectations around operational readiness, clinical evidence, lifecycle oversight, reliance, transparency, AI and cybersecurity. This edition covers:

  • NMPA's revised medical device GMP inspection framework, effective 1 November, affecting licensing, Class I filings and post-market supervision.
  • Swissmedic's revised Article 41 MPLO requirements, now valid, moving notifications to the Portal and addressing major digital and AI/ML system changes.
  • MyHealth@EU, CECP and ICH M13B developments from the European Commission and EMA.
  • Updated MHRA national assessment, pre-submission and variations guidance, plus Beyond ADMET on AI in medicines safety.
  • The Egyptian Drug Authority's new veterinary variations guidance and clinical-trial/GCP disclosure requirements.
  • FDA's new NAMs use-case database and draft robotically-assisted surgical-device guidance.
  • ENISA's AI-assisted software-development guidance and Threat Landscape 2026.
  • SAHPRA's new device/IVD import requirements and WHO's expanded medical-device prequalification.

Explore the update >>

๐ŸŽค In Case You Missed It

Your Commercial Training Is Part of HF Validation

Last Thursday, 376 people registered and 141 joined live from 26 countries to hear Denise Forkey , Director, Human Factors Strategy & Advisory at ClariMed, Inc., and Liz C. , CEO of Cumby Consulting. FDA's human factors guidance and IEC 62366-1 both count training as part of the user interface. When training is a design requirement, a risk control or a labeled requirement, the training customers get at launch should be materially the same as the training validation participants received.

Liz described receiving validated programs that assume every physician gives a day and a half and reads five documents in advance. "I'm like, that's not real," she said. Denise said the commercial team often hasn't been hired when validation training is developed.

In the live poll, 33 of 57 respondents said field-training people come in after HF validation, at or near launch, not at all, or they did not know.

FDA's May 2026 final guidance on HF content in marketing submissions lists training among the changes that decide how much HF information a modified device needs. Denise's example: critical tasks validated with live training, supervised practice and observed performance, then launched with a recorded video and a completion record. She called that a significant change that should go through HF validation. Liz's advice is to bring commercial in while validation training is planned. "Maybe it's just an hour conversation," she said.

Watch the replay >>

๐Ÿ”ฅ Postscript

Back from Prague

I'm still working through my notes from the TEAM-PRRC Annual Summit and will share them soon.

Register Now >>

Sean ๐Ÿ

Read this issue on LinkedIn โ†—

Want this every Sunday? One email. Every expert named. Unsubscribe in one click.
Subscribe

Recent sessions

All sessions โ†’
29 Oct 2026Want More Referrals? An MLVx Business Development Working Session 23 Oct 2026Want More Referrals: Turning Trust into Referrals 22 Oct 2026Clinical Project Management: The Hidden Complexity of Medical Device and IVD Studies